155 related articles for article (PubMed ID: 27027880)
1. New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.
Fu CL; Hsu LS; Liao YF; Hu MK
Arch Pharm (Weinheim); 2016 May; 349(5):327-41. PubMed ID: 27027880
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
[TBL] [Abstract][Full Text] [Related]
3. Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation.
Oliveri V; Bellia F; Pietropaolo A; Vecchio G
Chemistry; 2015 Sep; 21(40):14047-59. PubMed ID: 26298549
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
[TBL] [Abstract][Full Text] [Related]
5. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
[TBL] [Abstract][Full Text] [Related]
6. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
7. Clioquinol and other hydroxyquinoline derivatives inhibit Abeta(1-42) oligomer assembly.
LeVine H; Ding Q; Walker JA; Voss RS; Augelli-Szafran CE
Neurosci Lett; 2009 Nov; 465(1):99-103. PubMed ID: 19664688
[TBL] [Abstract][Full Text] [Related]
8. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
9. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity.
Crouch PJ; Savva MS; Hung LW; Donnelly PS; Mot AI; Parker SJ; Greenough MA; Volitakis I; Adlard PA; Cherny RA; Masters CL; Bush AI; Barnham KJ; White AR
J Neurochem; 2011 Oct; 119(1):220-30. PubMed ID: 21797865
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
[TBL] [Abstract][Full Text] [Related]
11. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.
Mao F; Yan J; Li J; Jia X; Miao H; Sun Y; Huang L; Li X
Org Biomol Chem; 2014 Aug; 12(31):5936-44. PubMed ID: 24986600
[TBL] [Abstract][Full Text] [Related]
12. Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
Zhang H; Zhang C; Dong XY; Zheng J; Sun Y
J Mol Recognit; 2018 Jun; 31(6):e2697. PubMed ID: 29318655
[TBL] [Abstract][Full Text] [Related]
13. Two macrocyclic polyamines as modulators of metal-mediated Aβ40 aggregation.
Yang Y; Chen T; Zhu S; Gu X; Jia X; Lu Y; Zhu L
Integr Biol (Camb); 2015 Jun; 7(6):655-62. PubMed ID: 25968625
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
[TBL] [Abstract][Full Text] [Related]
15. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
16. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
17. Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation.
Wang Z; Wang Y; Li W; Liu Z; Luo Z; Sun Y; Wu R; Huang L; Li X
Dalton Trans; 2015 Dec; 44(48):20913-25. PubMed ID: 26575390
[TBL] [Abstract][Full Text] [Related]
18. Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.
Prati F; Bergamini C; Fato R; Soukup O; Korabecny J; Andrisano V; Bartolini M; Bolognesi ML
ChemMedChem; 2016 Jun; 11(12):1284-95. PubMed ID: 26880501
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease.
Wang Z; Wang Y; Li W; Mao F; Sun Y; Huang L; Li X
ACS Chem Neurosci; 2014 Oct; 5(10):952-62. PubMed ID: 25121395
[TBL] [Abstract][Full Text] [Related]
20. Carnosine-LVFFARK-NH
Zhang H; Dong X; Sun Y
ACS Chem Neurosci; 2018 Nov; 9(11):2689-2700. PubMed ID: 30036471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
